Dairy Ads Pose Risk to Those with High Blood Pressure

Article

WASHINGTON, DC-The Physicians Committee for Responsible Medicine (PCRM) is asking the Federal Trade Commission (FTC) to stop the dairy industry from advertising that low-fat dairy products are good for those suffering form high blood pressure.

The advertisement is running in medical journals and is unsupported by scientific studies. It may be in violation of FTC rules. The ad claims "Dairy Makes the Difference in DASH." This is a reference to the Dietary Approaches to Stop Hypertension multicenter funded by the federal National Heart Lung and Blood Institute. However, the DASH study did not conclude that dairy product consumption is responsible for reducing blood pressure.

Hypertension, also known as the "silent killer" affects 50 million American adults and is prevalent among African Americans and the elderly.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.